PDS Biotechnology Corp 8-K

What Happened
On May 13, 2026, PDS Biotechnology Corporation announced a business update and reported its financial results for the quarter ended March 31, 2026 via a press release. The company furnished the press release as Exhibit 99.1 to its Form 8-K.

Key Details

• Filing date: May 13, 2026.
• Reporting period: quarter ended March 31, 2026.
• Press release attached as Exhibit 99.1 (document was furnished, not filed, under General Instruction B.2).
• The Form 8-K also includes the Inline XBRL cover page (Exhibit 104).

Why It Matters
This filing is the company’s official release of its latest quarterly results and a business update — essential information for investors tracking PDSB’s earnings, revenue, cash position, and operational progress. Note the disclosure is furnished (not filed), which affects legal incorporation and Section 18 liability; for the detailed financial figures and management commentary, review Exhibit 99.1 (the press release) or the company’s full SEC filings.